Original Research
Accepted on 30 Sep 2025
A phase Ib/II study of modakafusp alfa alone and in combination with pembrolizumab in patients with advanced or metastatic solid tumors
in Cancer Molecular Targets and Therapeutics
Original Research
Accepted on 30 Sep 2025
in Cancer Molecular Targets and Therapeutics
Original Research
Accepted on 30 Sep 2025
in Orthopedic Surgery
Mini Review
Accepted on 30 Sep 2025
in Immunological Tolerance and Regulation
Review
Accepted on 30 Sep 2025
in Atmospheric Remote Sensing
Original Research
Accepted on 30 Sep 2025
in Skin Physiology
Original Research
Accepted on 30 Sep 2025
in Veterinary Infectious Diseases
Original Research
Accepted on 30 Sep 2025
in Breast Cancer
Original Research
Accepted on 30 Sep 2025
in Neurogenomics
Original Research
Accepted on 30 Sep 2025
in Microbes and Innate Immunity
Original Research
Accepted on 30 Sep 2025
in Breast Cancer
Original Research
Accepted on 30 Sep 2025
in Brain Health and Clinical Neuroscience
Correction
Accepted on 30 Sep 2025
in Medicinal and Pharmaceutical Chemistry
Original Research
Accepted on 30 Sep 2025
in T Cell Biology
Correction
Accepted on 30 Sep 2025
in Green and Sustainable Chemistry
Original Research
Accepted on 30 Sep 2025
in Digital Education
Editorial
Accepted on 30 Sep 2025
in Biomedical Nanotechnology